Jul. 4 at 7:25 PM
$ELTP meh he should have never mentioned a sale of the company until he accepted an offer. Not the biggest mistake in the world.
But if we compare results, unprofitable
$1.6BN market cap
$HROW has guided for and is dreaming of
$40M in profit and an associated
$3BN market cap valuation.
We already have
$40M in profit.
And if we look at
$5.5BN market cap
$AMRX they have about
$70M in profit but it takes them
$3BN in revenue to get there (low margins).
$ANIP Twice our income. 6X our market cap.
The Purdue money is coming. So is the Anticoagulant money. No point in selling now. Especially when you see those fails to deliver from September. I’d avoid shorting here.
